Publications by authors named "Christel Wilkinson"

Claim this Profile
P
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open-Label Trial.
Hermine I Brunner, Jordi Antón, Inmaculada Calvo-Penadés, Richard Dimelow, Gerd Horneff, Christel Wilkinson

Arthritis Care Res (Hoboken)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme.
Toni Maslen, Ian N Bruce, David D'Cruz, Mihaela Ianosev, Damon L Bass, Christel Wilkinson

Lupus Sci Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis.
Christel Wilkinson, Robert B Henderson, Angela R Jones-Leone, Shaun M Flint, Mark Lennon

Arthritis Res Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder.
Ray Berard, Regan Fong, David J Carpenter, Christine Thomason, Christel Wilkinson

J Child Adolesc Psychopharmacol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.
Graham J Emslie, Karen Dineen Wagner, Stan Kutcher, Stan Krulewicz, Regan Fong, Christel Wilkinson

J Am Acad Child Adolesc Psychiatry· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis